Astrazeneca Pharma Ind Lt
₹6,764.50
-1.40%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.13.
- Comfortable interest cover: operating profit covers interest about 65.5 times.
- Return on equity is healthy at 23.3%.
- Return on capital employed is healthy at 29.3%.
- Net profit margin is 8.3%.
- Profit has compounded about 16% a year over five years.
- Sales have compounded about 23% a year over five years.
- Pays a dividend (yield about 0.53%).
- Has paid a dividend in each of the last 5 years on record.
- Promoters hold a majority stake (75%).
!Watch-points
- Recent profit growth (-18%) is slower than the five-year pace (16%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
7.29
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 16,911 Cr
Current Price₹ 6,764.50
High / Low₹ 9,849.50 / 6,750.00
Stock P/E99.99261
Book Value₹ 349.00
Dividend Yield0%
ROCE29.30%
ROE23.30%
Face Value₹ 2.00
Debt to Equity0.13
PEG Ratio6.50
EV / EBITDA58.49
Industry PE35.70
P/B Ratio19.376081
EPS₹ 75.01
Debt₹ 111 Cr
PAT Margin8.26%
Cash PAT₹ 217 Cr
ICR65.50
Promoter Holding75.00%
FII Holding2.68%
DII Holding6.08%
Public Holding16.24%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity